Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 20 Nov 2025

Efficacy and safety of tacrolimus in the treatment of interstitial pneumonia with autoimmune features: a retrospective study

in Respiratory Pharmacology

Yanzao Zhao
Xuemei Huang
Xinyue Cao
Jie Luo
Xi He
Qianhui Yang
Anji Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1721639

127 views

Review

Published on 19 Nov 2025

Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer

in Respiratory Pharmacology

Xin Xie
Qian Chen
Cui Guo
Jinhao Zeng
Qingying He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602581

568 views

Review

Accepted on 17 Nov 2025

Regulatory Mechanisms of Luteolin in Inflammatory Respiratory Diseases

in Respiratory Pharmacology

Peidao Sun
Xiangchen Chen
Yuhang Wang
Xiaolin Wang
Kejing Li
Hongbo Song
Jinlong Mao

Frontiers in Pharmacology

112 views

Case Report

Published on 14 Nov 2025

Case Report: Telitacicept for interstitial lung disease associated with idiopathic inflammatory myopathies: an observational study

in Respiratory Pharmacology

Xue Chen
Mengshan Li
MingFang Sun
XinTong Xie
Xi Zhao
Yan Chen
HuanZi Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1647543

617 views

Original Research

Published on 13 Nov 2025

EGCG alleviates PM2.5-induced lung injury via activation of PPAR-γ to suppress inflammation and oxidative stress

in Respiratory Pharmacology

Kai Liu
Dean Wu
Chunyan Li
Dongxia Tang
Chuanwei Xu
Tongjing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1695785

356 views

Original Research

Published on 13 Nov 2025

Stability of formoterol concentration in scalp hair of patients using maintenance formoterol therapy for asthma or COPD (INCTFISH)

in Respiratory Pharmacology

E. Sportel
K. Wagelaar
M. Brusse-Keizer
J. van der Palen
H. van Veen
M. Wessels
J. van Boven
D. Touw
K. Movig

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1693712

420 views

Review

Published on 07 Nov 2025

Repolarization of inflammatory macrophages into reparative stage targeting cannabinoid receptor2: a potential perspective to dampen lung injury/ARDS

in Respiratory Pharmacology

Chloe Benedict
Jagdish Chandra Joshi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1623857

395 views

Original Research

Published on 06 Nov 2025

Somatostatin receptors 3 and 5 potentiate cholinergic-nerve-mediated contraction in human bronchus

in Respiratory Pharmacology

Marion Brollo
Stanislas Grassin-Delyle
Camille Roquencourt
Elisabeth Longchampt
Isabelle Miguet-Besson
Matthieu Glorion
Hélène Salvator
Philippe Devillier

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1677183

531 views

Original Research

Accepted on 03 Nov 2025

Diacetyl-Induced Bronchiolitis Obliterans Involves Ubiquitin C Upregulation and Fibrosis-Related Gene Activation in Rats

in Respiratory Pharmacology

Hailian Wang
Wen Jiang
Junchao Xiao
Yan Geng
Qing Ye
Wei Ge

Frontiers in Pharmacology

130 views

Original Research

Accepted on 31 Oct 2025

Development and validation of a clinical prediction model for in-hospital mortality of severe pneumonia based on machine learning

in Respiratory Pharmacology

Kai Xie
Xiajin Huang
Zhen Li
Wenjing Yin
Xiaoxuan He
Xinyu Miao
Haifeng Wang

Frontiers in Pharmacology

170 views

Original Research

Published on 30 Oct 2025

Therapeutic efficacy of deslanoside in oleic acid-induced acute lung injury in rabbits: Implications for clinical drug use and pharmacological strategies

in Respiratory Pharmacology

Rong Hu
Yi Zheng
Ning Li
Yong Pan
Xiaozhen Zhou
Lu Liu
Dizheng Liao
Yafei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1683838

504 views

Review

Published on 29 Oct 2025

Medicinal plants and compounds for chronic bronchitis treatment: efficacy and action mechanisms

in Respiratory Pharmacology

Wei Ding
Danni Chen
Jiawang Li
Yan Wang
Xiangyun Chen
Yihe Xu
Zhen Yang
Zhenhong Liu
Hongxia Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1674079

972 views

Original Research

Published on 29 Oct 2025

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR

in Respiratory Pharmacology

Iwona Pranke
Valeria Capurro
Benoit Chevalier
Emanuela Pesce
Valeria Tomati
Cristina Pastorino
Mairead Kelly-Aubert
Aurelie Hatton
Elise Dreano
Mariateresa Lena

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661417

1,284 views

Review

Published on 27 Oct 2025

The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research

in Respiratory Pharmacology

Mingjun Wu
Qian Yang
Youcheng Xie
Yan Hou
Qingliang Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1649570

813 views

Original Research

Published on 24 Oct 2025

Montelukast: risk of mental disorders vs. efficacy–a meta-analysis

in Respiratory Pharmacology

Marharyta Sobczak
Rafał Pawliczak

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1659852

1,500 views

Review

Published on 23 Oct 2025

Diabetes mellitus-driven pulmonary injury: multidimensional mechanisms linking metabolic dysregulation to gut-lung axis and promising therapies

in Respiratory Pharmacology

Jiacheng Sun
Junyang Chen
Yuntian Shen
Xinlei Yao
Hualin Sun
Bingqian Chen
Jian Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689522

1,095 views